2012 Hospice Palliate Presentation 
Hospice News
MARCH 12, 2024
Program integrity and an onslaught of audits are top of mind for many hospice providers in 2024. The organizations earlier this year presented their findings , published today, to members of Congress and the U.S. Centers for Medicare & Medicaid Services (CMS). The impetus for the audit was primarily related to billing errors.
Hospice News
MARCH 25, 2024
Arizona-based Stoneridge Hospice launched services in 2020 with an aim to address a swelling aging population’s growing need for end-of-life care. Stoneridge Hospice provides home-based hospice and also contracts with other providers to offer facility-based services. Stoneridge Hospice launched in 2020.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hospice News
JUNE 28, 2023
Hospice of the Chesapeake Appoints New CMO Maryland-based Hospice of the Chesapeake recently named Dr. Marny Fetzer as its new chief medical officer. Fetzer is currently system medical director for palliative care and hospice services at Illinois-based Ascension Health.
GeriPal
MARCH 7, 2024
We also invited Beth Klint to speak about the doula’s role within a traditional hospice organization. We are delighted to welcome Jane Euler, who is lead doula and co-founder of Present for You, which is a benefit LLC company that provides doula support at the end-of-life. Why Beth? Jane, welcome to the GeriPal podcast.
Pallimed
SEPTEMBER 12, 2022
PROP and Chou petitioned the Food and Drug Administration (FDA) to change opioid labeling in July 2012 (29, 30), but FDA rejected PROP’s call for a maximum daily dose of opioid analgesia of 100 morphine milligram equivalents (MME) based on a lack of supporting data (31). Kollas provided testimony at a 2004 Congressional Hearing on OxyContin.
Pallimed
MAY 3, 2021
PROP Petition to the FDA on Opioid Labeling The Petition is Filed In its first effort to influence national opioid policy, in July 2012, PROP submitted a Petition to the Food and Drug Administration (FDA) calling for a change in labeling of opioid analgesics (8).
Pallimed
SEPTEMBER 17, 2021
Lewis PhD, Beverly Schechtman and Carrie Judy “I'm present. More importantly, Oregon Health and Science University (OHSU), Chou’s employer, announced on August 31, 2012, that it had received from AHRQ a five-year contract to serve as an Evidence-Based Practice Center, which funded Chou’s work (33). Kollas MD, Terri A.
Expert insights. Personalized for you.
232 
Let's personalize your content